A precision medicine drug discovery pipeline to identify dual CDK2/9 inhibition as a novel treatment for colorectal cancer.

Roham Salman Roghani,Ali Sanjari moghaddam,Gabrielle Rupprecht,Erdem Altunel,So Young Kim,Shannon J. McCall,Beatrice C Thomas,Katie Ware,Jason A. Somarelli,David S. Hsu

A precision medicine drug discovery pipeline to identify dual CDK2/9 inhibition as a novel treatment for colorectal cancer.

2020

Roham Salman Roghani
Ali Sanjari moghaddam
Gabrielle Rupprecht
Erdem Altunel
So Young Kim
Shannon J. McCall
Beatrice C Thomas
Katie Ware
Jason A. Somarelli
David S. Hsu

e16056Background: Colorectal cancer (CRC) is the 3rdmost common form of cancer in the US, responsible for over 50,000 death each year. Therapeutic options for advanced colorectal cancer are limited...

Keywords:

Oncology
Colorectal cancer
Internal medicine
Precision medicine
Drug discovery
Pathology
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations